The effects of vitamin D2 or D3supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial

Journal article

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.London – Block grant from Tower Hamlets Primary Care NHS Trust and East London CLRN. Cambridge – From the operational budget of Medical Research Council Epidemiology Unit (MC_UP_A100_1003)

Authors: Menon, RK; Rickard, AP; Mannan, N; Timms, PM; Sharp, SJ

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: BioMed Central
• Journal: BMC Public Health
• Volume: 13
• Issue: 1
• Pages: 999-999
• Publication date: 2013-10-23
• DOI: 10.1186/1471-2458-13-999
• EISSN: 1471-2458
• ISSN: 1471-2458
• Language: English
• Keywords: Vitamin D and neurology; Cholecalciferol; Medicine; Diabetes mellitus; Placebo; Type 2 diabetes; Pathology; Randomized controlled trial; Ergocalciferol; Internal medicine; Endocrinology; Epidemiology